Otros idiomas Akari Therapeutics, Plc

Acciones

AKTX

US00972G2075

Diferido Nasdaq Otros sitios de cotización 17:13:59 14/06/2024			Varia. Cinco días.	Varia. 1 de enero.
3,1 ^USD	+1,64 %		+39,01 %	-0,64 %

13/06	La renta variable europea cotizó en EE.UU. con recibos de depósito estadounidenses a la baja en la sesión del jueves	MT
12/06	Las acciones europeas negociadas en EE.UU. como recibos de depósito estadounidenses suben con fuerza en la jornada del miércoles	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

European Equities Traded in the US as American Depositary Receipts Sharply Lower in Thursday Trading	13/06
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading	12/06
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Tuesday Trading	11/06
Tech Firms Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading	06/06
Akari Therapeutics, plc Appoints Samir R. Patel as Interim President	05/06
Akari Therapeutics : 2023 Annual Report	05/06
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading	04/06
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading	03/06
European Equities Traded in US as American Depositary Receipts Rise Friday, Poised to End Week Lower	31/05
Akari Therapeutics, Plc announced that it has received $14.392174 million in funding	31/05
Akari Therapeutics, Plc announced that it expects to receive $15.192172 million in funding	29/05
European Equities Traded in the US as American Depositary Receipts Trend Higher Friday, End Week Marginally Lower	24/05
Tech Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading	23/05
European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading	20/05
Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights	16/05
Akari Therapeutics, Plc announced that it has received $0.5 million in funding	16/05
Akari Therapeutics, Plc Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	10/05
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Wednesday Trading	08/05
Akari Therapeutics, plc Announces the Resignation of Rachelle Jacques from the Board of Directors	07/05

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Akari Therapeutics, Plc

Acciones

AKTX

US00972G2075

Otros idiomas

Filtros